Manhard Kimberly: insider trades.
Manhard Kimberly reported 5 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($279K), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 5
- Companies
- 1
- Name as filed
- MANHARD KIMBERLY
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Inhibrx Biosciences, Inc. (INBX) | Director | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Inhibrx Biosciences, Inc. | S | 500 | $105.05 | 7,500 | Form 4 |
| 2026-09-14 | Inhibrx Biosciences, Inc. | S | 500 | $110.26 | 8,000 | Form 4 |
| 2026-09-11 | Inhibrx Biosciences, Inc. | S | 500 | $111.78 | 8,500 | Form 4 |
| 2026-09-09 | Inhibrx Biosciences, Inc. | S | 500 | $115.8 | 9,000 | Form 4 |
| 2026-09-08 | Inhibrx Biosciences, Inc. | S | 500 | $115.14 | 9,500 | Form 4 |
Questions
What stock did Manhard Kimberly buy or sell?
Manhard Kimberly reported 5 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($279K), across 1 company.
Is Manhard Kimberly the same person as other filers with this name?
This page covers SEC CIK 1202094 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/manhard-kimberly-1202094.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.